NorthX Biologics at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
NorthX Biologics takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 227. Its program centres on taking outer membrane vesicle (OMV) vaccine technology into clinical use. It appears alongside Abera Bioscience and reflects its role as a contract manufacturer with two facilities that make biologics to drug-quality standards.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Swedish CDMO with two GMP facilities supporting development and manufacturing of biologics. | Booth Exhibiting at Booth 227 Talk Wed Oct 21 10:30 From Innovation to Impact: Translating OMV Vaccine Technology into Clinical Reality How a developer and a contract manufacturer take vaccines made from outer membrane vesicles, tiny bacterial bubbles, from research toward clinical trials. |
Instantly find 20 buyers from NorthX Biologics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction